At the time of writing, Mirum Pharmaceuticals Inc [MIRM] stock is trading at $53.46, up 6.35%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MIRM shares have gain 10.48% over the last week, with a monthly amount glided 15.27%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on April 17, 2024, and set its price target to $48. On December 18, 2023, H.C. Wainwright reiterated its Buy rating and revised its price target to $58 on the stock. Morgan Stanley initiated its recommendation with a Overweight and recommended $60 as its price target on November 13, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on October 24, 2023, and assigned it a price target of $50.
For the past year, the stock price of Mirum Pharmaceuticals Inc fluctuated between $35.11 and $54.23. Currently, Wall Street analysts expect the stock to reach $57.25 within the next 12 months. Mirum Pharmaceuticals Inc [NASDAQ: MIRM] shares were valued at $53.46 at the most recent close of the market. An investor can expect a potential return of 7.09% based on the average MIRM price forecast.
Analyzing the MIRM fundamentals
According to Mirum Pharmaceuticals Inc [NASDAQ:MIRM], the company’s sales were 379.25M for trailing twelve months, which represents an 61.20% jump. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.34 and Total Capital is -0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 51.48 points at the first support level, and at 49.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 54.65, and for the 2nd resistance point, it is at 55.84.
Ratios To Look Out For
It is important to note that Mirum Pharmaceuticals Inc [NASDAQ:MIRM] has a current ratio of 3.22. In addition, the Quick Ratio stands at 3.04 and the Cash Ratio stands at 1.66. Considering the valuation of this stock, the price to sales ratio is 6.98, the price to book ratio is 11.33.
Transactions by insiders
Recent insider trading involved Howe Jolanda, SVP, GLOBAL CONTROLLER, that happened on Jul 02 ’25 when 564.0 shares were sold. SVP, GLOBAL CONTROLLER, Howe Jolanda completed a deal on Jul 03 ’25 to sell 477.0 shares. Meanwhile, Officer JOLANDA MARIE HOWE bought 477.0 shares on Jul 03 ’25.
